# Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS

> **NCT07380997** · — · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 411 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)
- Microbiome Dysbiosis
- Multiomics Analysis
- Metabolomics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07380997
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 411 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380997, "Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07380997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*